GENEVA, Feb. 4 -- GENENTECH, INC. (1 DNA WaySouth San Francisco, California 94080-4990) filed a patent application (PCT/US2025/039012) for "TREATMENT OF OPHTHALMOLOGIC DISEASES" on Jul 24, 2025. With publication no. WO/2026/024924, the details related to the patent application was published on Jan 29, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WILLIS, Jeffrey R. (c/o Genentech, Inc.1 DNA WaySouth San Francisco, California 94080-4990)
Abstract: The current invention relates to antibodies, which bind to human vascular endothelial growth factor (VEGF) and human angiopoietin-2 (ANG2) for u...